Abstract
Improvements in positron emission tomography (PET) technology have contributed to increased diagnostic accuracy in patients with large-vessel vasculitis (LVV) over the last decades. Many systematic reviews and meta-analyses were conducted, and earlier diagnosis by 18F-FDG PET can be made in patients suspected of having LVV. Two subtypes, Takayasu arteritis and giant cell arteritis, will progress when poorly responding to corticosteroids and augmented immunosuppression. In most patients, disease activity cannot be monitored by laboratory tests alone; therefore, glucose metabolism may be a source for possible biomarkers. In this review, we present current concepts regarding 18F-FDG PET/CT imaging standards.
Similar content being viewed by others
References
Myklebust G, Gran JT. A prospective study of 287 patients with polymyalgia rheumatic and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis’. Br J Rheumatol. 1996;35:1161–8.
Treglia G, Mattoli MV, Leccisotti L, et al. Usefulness of whole body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with large-vessel vasculitis: a systematic review. Clin Rheumatol. 2011;30(10):1265–75.
Versari A, Pipitone N, Casali M, Jamar F, et al. Use of imaging techniques in large vessel vasculitis and related conditions. Q J Nucl Med Mol Imaging. 2018;62(1):34–9.
Duftner C, Dejaco C, Sepriano A, Falzon L, Schmidt WA, Ramiro S. Imaging in diagnosis, outcome prediction and monitoring of large vessel vasculitis: a systematic literature review and meta-analysis informing the ULAR recommendations. RMD Open. 2018;4:e000612.
Incerti E, Tombetti E, Fallanca F, Baldissera EM, Alongi P, Tombolini E, et al. (18)F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu’s arteritis. Eur J Nucl Med Mol Imaging. 2017;44(7):1109–18.
Barra L, Kanji T, Malette J, Pagnoux C. CanVasc. Imaging modalities for the diagnosis and disease activity assessment of Takayasu’s arteritis: A systematic review and meta-analysis. Autoimmun Rev. 2018;17:175–87.
Jiemy WF, Heeringa P, Kamps JAAM, van der Laken CJ, Slart RHIJ, et al. Positron emission tomography (PET) and single photon emission computed tomography (SPECT) imaging of macrophages in large vessel vasculitis: current status and future prospects. Autoimmun Rev. 2018;17:715–26.
Soussan M, Nicolas P, Schramm C, Katsahian S, Pop G, Fain O, et al. Management of large-vessel vasculitis with FDG-PET: a systematic literature review and meta-analysis. Medicine (Baltimore). 2015;94(14):e622.
Lee SW, Kim SJ, Seo Y, Jeong SY, Ahn BC, Lee J. F-18 FDG PET for assessment of disease activity of large vessel vasculitis: a systematic review and meta-analysis. J Nucl Cardiol. 2019;26(1):59–67.
Slart RHJA, Glaudemans AWJM, Chareonthaitawee P, Treglia G, Besson FL, Bley TA, Blockmans D, et al. FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. Eur J Nucl Med Mol Imaging. 2018;45:1250–69.
Dejaco C, Ramiro S, Duftner C, Besson FL, Bley TA, Blockmans D, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis. 2018;77:636–43.
Nielsen BD, Gormsen LC, Hnsen T, Keller KK, Therkildsen P, Hauge EM. Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy. Eur J Nucl Med Mol Imaging. 2018;45:1119–28.
Olthofa SC, Krumma P, Henesb J, Nikolaoua K, la Fougèrec C, Pfannenberga C, et al. Imaging giant cell arteritis and aortitis in contrast enhanced 18F-FDG PET/ CT: Which imaging score correlates best with laboratory inflammation markers? Eur J Radiol. 2018;99:94–102.
Buttgereit F, Dejaco C, Matteson EL, Dasgupta B. Polymyalgia rheumatica and giant cell arteritis: a systematic review. JAMA. 2016;315:2442–58.
Hautzel H, Sander O, Heinzal A, Schneider M, Muller HW. Assessment of large-vessel involvement in giant cell arteritis with 18F-FDG PET: introducing an ROC-analysis-based cutoff ratio. J Nucl Med. 2008;49:1107–13.
Soriano A, Pazzola G, Boiardi L, Casali M, Muratore F, Pipitone N, et al. Distribution patterns of 18F-fluorodeoxyglucose in large vessels of Takayasu’s and giant cell arteritis using positron emission tomography. Clin Exp Rheumatol. 2018;36:S99–106.
Grayson PC, Alehashemi S, Bagheri AA, Civelek AC, Cupps TR, Kaplan MJ, et al. 18F-Fluorodeoxyglucose-positron emission tomography as an imaging biomarker in a prospective, longitudinal cohort of patients with large vessel vasculitis. Arthritis Rheumatol. 2018;70:439–49.
Emsen B, Benalia K, Mahidaa B, Larivièreb D, Le Guludeca D, Papob T, et al. Comparison between visual and numerical metrics for the evaluation of patients with Takayasu arteritis with 18F-FDG-PET. Nucl Med Commun. 2018;39:779–88.
Rodríguez IM, Alonso M, Quirce R, Bonilla JJ, Amador NM, Pha MT, et al. 18F-FDG PET/CT in the follow-up of large-vessel vasculitis: a study of 37 consecutive patients. Semin Arthritis Rheum. 2018;47:530–7.
Yuge S, Nakatani K, Yoshino K, Koyama T. Diagnosing polymyalgia rheumatica on 18 F-FDG PET/CT: typical uptake patterns. Ann Nucl Med. 2018;32:573–5677.
Vitiello G, Battaglini CO, Carli G, Radice A, Matucci A, Vultaggio A, et al. Tocilizumab in giant cell arteritis: a real-life retrospective study. Angiology. 2018;69:763–9.
Banerjee S, Quinn KA, Gribbons KB, Rosenblum JS, Civelek AC, Novakovich E, et al. Effect of treatment on imaging, clinical, and serologic assessments of disease activity in large-vessel vasculitis. J Rheumatol. 2020;47:99–107.
Dellavedova L, Carletto M, Faggioli P, Sciascera A, Del Sole A, Mazzone A, et al. The prognostic value of baseline 18F-FDG PET/CT in steroid-naïve large-vessel vasculitis: introduction of volume-based parameters. Eur J Nucl Med Mol Imaging. 2016;43:340–8.
Muratore F, Crescentini F, Spaggiari L, Pazzola G, Casali M, Boiardi L, et al. Aortic dilatation in patients with large vessel vasculitis: a longitudinal case control study using PET/CT. Semin Arthritis Rheum. 2019;48:1074–82.
Acknowledgements
We gratefully appreciate the cooperation of the following members, Jun Isogai, MD, PhD, Asahi General Hospital and Yoichi Machida, MD, PhD, Kameda Medical Center.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
We have no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Tateishi, U., Tsuchiya, J. & Yokoyama, K. Large vessel vasculitis: imaging standards of 18F-FDG PET/CT. Jpn J Radiol 39, 225–232 (2021). https://doi.org/10.1007/s11604-020-01059-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11604-020-01059-4